KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to $9.4 million.

  • Neogenomics' Other Non-Current Assets rose 5959.9% to $9.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.4 million, marking a year-over-year increase of 5959.9%. This contributed to the annual value of $9.4 million for FY2025, which is 5959.9% up from last year.
  • According to the latest figures from Q4 2025, Neogenomics' Other Non-Current Assets is $9.4 million, which was up 5959.9% from $8.2 million recorded in Q3 2025.
  • Neogenomics' Other Non-Current Assets' 5-year high stood at $11.1 million during Q1 2021, with a 5-year trough of $4.1 million in Q2 2024.
  • In the last 5 years, Neogenomics' Other Non-Current Assets had a median value of $6.2 million in 2022 and averaged $6.5 million.
  • In the last 5 years, Neogenomics' Other Non-Current Assets tumbled by 7870.11% in 2021 and then soared by 7489.57% in 2025.
  • Quarter analysis of 5 years shows Neogenomics' Other Non-Current Assets stood at $7.2 million in 2021, then decreased by 28.72% to $5.1 million in 2022, then fell by 7.18% to $4.7 million in 2023, then increased by 24.12% to $5.9 million in 2024, then soared by 59.6% to $9.4 million in 2025.
  • Its Other Non-Current Assets stands at $9.4 million for Q4 2025, versus $8.2 million for Q3 2025 and $7.1 million for Q2 2025.